CELL FUSION-INDUCING VACCINIA VIRUS AND USE THEREOF

The purpose of the present invention is to provide: a vaccinia virus that induces cell fusion of infected cells; and a method for producing the same. The present invention is a vaccinia virus which lacks the function of the K2L gene or the HA gene, or both the functions of the K2L gene and the Ha ge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NAKAMURA TAKAFUMI, KUWANO NOZOMI, NAKATAKE MOTOMU, KUROSAKI HAJIME
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NAKAMURA TAKAFUMI
KUWANO NOZOMI
NAKATAKE MOTOMU
KUROSAKI HAJIME
description The purpose of the present invention is to provide: a vaccinia virus that induces cell fusion of infected cells; and a method for producing the same. The present invention is a vaccinia virus which lacks the function of the K2L gene or the HA gene, or both the functions of the K2L gene and the Ha gene and is mutated to cause specific cell fusion of infected cells, in which cell fusion of the infected cells occurs to thereby induce cell death. 本发明的目的在于提供一种诱导受感染细胞的细胞融合的痘苗病毒及其制备方法。本发明是一种突变的痘苗病毒,其能够引起受感染细胞的特异性细胞融合,其中,K2L基因或HA基因、或者K2L基因和HA基因的功能发生了缺陷,所述痘苗病毒引起受感染细胞的细胞融合,诱导细胞死亡。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN113840914A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN113840914A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN113840914A3</originalsourceid><addsrcrecordid>eNrjZDB2dvXxUXALDfb099P19HMJdfb0c1cIc3QG0p6OCmGeQaHBCo5-Lgqhwa4KIR6uQa7-bjwMrGmJOcWpvFCam0HRzTXE2UM3tSA_PrW4IDE5NS-1JN7Zz9DQ2MLEwNLQxNGYGDUAjrAm7g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CELL FUSION-INDUCING VACCINIA VIRUS AND USE THEREOF</title><source>esp@cenet</source><creator>NAKAMURA TAKAFUMI ; KUWANO NOZOMI ; NAKATAKE MOTOMU ; KUROSAKI HAJIME</creator><creatorcontrib>NAKAMURA TAKAFUMI ; KUWANO NOZOMI ; NAKATAKE MOTOMU ; KUROSAKI HAJIME</creatorcontrib><description>The purpose of the present invention is to provide: a vaccinia virus that induces cell fusion of infected cells; and a method for producing the same. The present invention is a vaccinia virus which lacks the function of the K2L gene or the HA gene, or both the functions of the K2L gene and the Ha gene and is mutated to cause specific cell fusion of infected cells, in which cell fusion of the infected cells occurs to thereby induce cell death. 本发明的目的在于提供一种诱导受感染细胞的细胞融合的痘苗病毒及其制备方法。本发明是一种突变的痘苗病毒,其能够引起受感染细胞的特异性细胞融合,其中,K2L基因或HA基因、或者K2L基因和HA基因的功能发生了缺陷,所述痘苗病毒引起受感染细胞的细胞融合,诱导细胞死亡。</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211224&amp;DB=EPODOC&amp;CC=CN&amp;NR=113840914A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211224&amp;DB=EPODOC&amp;CC=CN&amp;NR=113840914A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NAKAMURA TAKAFUMI</creatorcontrib><creatorcontrib>KUWANO NOZOMI</creatorcontrib><creatorcontrib>NAKATAKE MOTOMU</creatorcontrib><creatorcontrib>KUROSAKI HAJIME</creatorcontrib><title>CELL FUSION-INDUCING VACCINIA VIRUS AND USE THEREOF</title><description>The purpose of the present invention is to provide: a vaccinia virus that induces cell fusion of infected cells; and a method for producing the same. The present invention is a vaccinia virus which lacks the function of the K2L gene or the HA gene, or both the functions of the K2L gene and the Ha gene and is mutated to cause specific cell fusion of infected cells, in which cell fusion of the infected cells occurs to thereby induce cell death. 本发明的目的在于提供一种诱导受感染细胞的细胞融合的痘苗病毒及其制备方法。本发明是一种突变的痘苗病毒,其能够引起受感染细胞的特异性细胞融合,其中,K2L基因或HA基因、或者K2L基因和HA基因的功能发生了缺陷,所述痘苗病毒引起受感染细胞的细胞融合,诱导细胞死亡。</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB2dvXxUXALDfb099P19HMJdfb0c1cIc3QG0p6OCmGeQaHBCo5-Lgqhwa4KIR6uQa7-bjwMrGmJOcWpvFCam0HRzTXE2UM3tSA_PrW4IDE5NS-1JN7Zz9DQ2MLEwNLQxNGYGDUAjrAm7g</recordid><startdate>20211224</startdate><enddate>20211224</enddate><creator>NAKAMURA TAKAFUMI</creator><creator>KUWANO NOZOMI</creator><creator>NAKATAKE MOTOMU</creator><creator>KUROSAKI HAJIME</creator><scope>EVB</scope></search><sort><creationdate>20211224</creationdate><title>CELL FUSION-INDUCING VACCINIA VIRUS AND USE THEREOF</title><author>NAKAMURA TAKAFUMI ; KUWANO NOZOMI ; NAKATAKE MOTOMU ; KUROSAKI HAJIME</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN113840914A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>NAKAMURA TAKAFUMI</creatorcontrib><creatorcontrib>KUWANO NOZOMI</creatorcontrib><creatorcontrib>NAKATAKE MOTOMU</creatorcontrib><creatorcontrib>KUROSAKI HAJIME</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NAKAMURA TAKAFUMI</au><au>KUWANO NOZOMI</au><au>NAKATAKE MOTOMU</au><au>KUROSAKI HAJIME</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CELL FUSION-INDUCING VACCINIA VIRUS AND USE THEREOF</title><date>2021-12-24</date><risdate>2021</risdate><abstract>The purpose of the present invention is to provide: a vaccinia virus that induces cell fusion of infected cells; and a method for producing the same. The present invention is a vaccinia virus which lacks the function of the K2L gene or the HA gene, or both the functions of the K2L gene and the Ha gene and is mutated to cause specific cell fusion of infected cells, in which cell fusion of the infected cells occurs to thereby induce cell death. 本发明的目的在于提供一种诱导受感染细胞的细胞融合的痘苗病毒及其制备方法。本发明是一种突变的痘苗病毒,其能够引起受感染细胞的特异性细胞融合,其中,K2L基因或HA基因、或者K2L基因和HA基因的功能发生了缺陷,所述痘苗病毒引起受感染细胞的细胞融合,诱导细胞死亡。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN113840914A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title CELL FUSION-INDUCING VACCINIA VIRUS AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A39%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NAKAMURA%20TAKAFUMI&rft.date=2021-12-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN113840914A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true